Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer

Chemotherapy decreases the risk of relapse and mortality in early-stage breast cancer (BC), but it comes with the risk of toxicity. Chemotherapy efficacy depends on relative dose intensity (RDI), and an RDI

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research : BCR 2017-08, Vol.19 (1), p.101-101, Article 101
Hauptverfasser:	Yuan, Yuan, Vora, Nilesh, Sun, Can-Lan, Li, Daneng, Soto-Perez-de-Celis, Enrique, Mortimer, Joanne, Luu, The-Hang, Somlo, George, Waisman, James, Smith, David, Chao, Joseph, Katheria, Vani, Synold, Timothy, Tran, Vivi, Mi, Shu, Levi, Abrahm, Arsenyan, Anait, Choi, Jennifer, Zavala, Laura, Yost, Susan, Hurria, Arti
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of Daily Living Adult Age Aged Aged, 80 and over Aging Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological markers Biomarkers Blood coagulation Blood Coagulation Factors Breast Cancer Breast Neoplasms - blood Breast Neoplasms - drug therapy Breast Neoplasms - pathology C-Reactive Protein Chemotherapy Coagulation Coagulation factors Comorbidity Cytokines Drug dosages Female Fibrin Fibrinogen Degradation Products Frailty Humans Inflammation Inflammation Mediators - blood Interleukin 6 Interleukin-6 - blood Medical prognosis Middle Aged Neoplasm Staging Older adults Older people Patients Peripheral blood Quality of Life Toxicity Treatment Outcome Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Chemotherapy decreases the risk of relapse and mortality in early-stage breast cancer (BC), but it comes with the risk of toxicity. Chemotherapy efficacy depends on relative dose intensity (RDI), and an RDI
ISSN:	1465-542X 1465-5411 1465-542X
DOI:	10.1186/s13058-017-0895-5